nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—IKBKB—Auranofin—psoriatic arthritis	0.302	0.681	CbGbCtD
Acetylsalicylic acid—migraine—Prednisone—psoriatic arthritis	0.144	0.341	CpDpCtD
Acetylsalicylic acid—osteoarthritis—Prednisone—psoriatic arthritis	0.14	0.33	CpDpCtD
Acetylsalicylic acid—osteoarthritis—Methylprednisolone—psoriatic arthritis	0.14	0.33	CpDpCtD
Acetylsalicylic acid—ALB—Auranofin—psoriatic arthritis	0.0273	0.0616	CbGbCtD
Acetylsalicylic acid—PTGS2—Triamcinolone—psoriatic arthritis	0.0172	0.0389	CbGbCtD
Acetylsalicylic acid—PTGS2—Betamethasone—psoriatic arthritis	0.0148	0.0334	CbGbCtD
Acetylsalicylic acid—SLC22A7—Methotrexate—psoriatic arthritis	0.012	0.0272	CbGbCtD
Acetylsalicylic acid—ALB—Prednisone—psoriatic arthritis	0.00868	0.0196	CbGbCtD
Acetylsalicylic acid—PTGS2—Dexamethasone—psoriatic arthritis	0.00859	0.0194	CbGbCtD
Acetylsalicylic acid—HSPA5—skeletal joint—psoriatic arthritis	0.00833	0.262	CbGeAlD
Acetylsalicylic acid—ABCB1—Methylprednisolone—psoriatic arthritis	0.0075	0.0169	CbGbCtD
Acetylsalicylic acid—CYP2C19—Prednisone—psoriatic arthritis	0.00563	0.0127	CbGbCtD
Acetylsalicylic acid—SLC22A6—Methotrexate—psoriatic arthritis	0.00511	0.0115	CbGbCtD
Acetylsalicylic acid—HSPA5—Apoptosis-related network due to altered Notch3 in ovarian cancer—CARD14—psoriatic arthritis	0.00506	0.0776	CbGpPWpGaD
Acetylsalicylic acid—TP53—manus—psoriatic arthritis	0.00502	0.158	CbGeAlD
Acetylsalicylic acid—TP53—manual digit—psoriatic arthritis	0.00492	0.155	CbGeAlD
Acetylsalicylic acid—ABCB1—Betamethasone—psoriatic arthritis	0.00487	0.011	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisolone—psoriatic arthritis	0.00481	0.0109	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisone—psoriatic arthritis	0.00454	0.0103	CbGbCtD
Acetylsalicylic acid—ALB—Methotrexate—psoriatic arthritis	0.00436	0.00984	CbGbCtD
Acetylsalicylic acid—CYP2C8—Dexamethasone—psoriatic arthritis	0.00419	0.00946	CbGbCtD
Acetylsalicylic acid—CYP2C19—Dexamethasone—psoriatic arthritis	0.00351	0.00793	CbGbCtD
Acetylsalicylic acid—CYP2C9—Dexamethasone—psoriatic arthritis	0.00292	0.0066	CbGbCtD
Acetylsalicylic acid—ABCB1—Dexamethasone—psoriatic arthritis	0.00283	0.0064	CbGbCtD
Acetylsalicylic acid—HSPA5—Antigen Presentation: Folding, assembly and peptide loading of class I MHC—HLA-C—psoriatic arthritis	0.00238	0.0366	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Atypical NF-kappaB pathway—REL—psoriatic arthritis	0.00229	0.0351	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Methotrexate—psoriatic arthritis	0.00228	0.00514	CbGbCtD
Acetylsalicylic acid—NFKBIA—IL23-mediated signaling events—IL23R—psoriatic arthritis	0.00223	0.0341	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—IL23-mediated signaling events—IL23A—psoriatic arthritis	0.00189	0.029	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—NOD pathway—MEFV—psoriatic arthritis	0.00174	0.0267	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—skeletal joint—psoriatic arthritis	0.00167	0.0525	CbGeAlD
Acetylsalicylic acid—IKBKB—IL17 signaling pathway—TRAF3IP2—psoriatic arthritis	0.0015	0.0231	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Antigen Presentation: Folding, assembly and peptide loading of class I MHC—HLA-B—psoriatic arthritis	0.00141	0.0216	CbGpPWpGaD
Acetylsalicylic acid—TP53—skin of body—psoriatic arthritis	0.00131	0.0411	CbGeAlD
Acetylsalicylic acid—NFKBIA—skin of body—psoriatic arthritis	0.00128	0.0404	CbGeAlD
Acetylsalicylic acid—PTGS2—synovial membrane of synovial joint—psoriatic arthritis	0.00127	0.0398	CbGeAlD
Acetylsalicylic acid—HSPA5—skin of body—psoriatic arthritis	0.00126	0.0396	CbGeAlD
Acetylsalicylic acid—NFKBIA—Canonical NF-kappaB pathway—NOD2—psoriatic arthritis	0.00104	0.016	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Atypical NF-kappaB pathway—REL—psoriatic arthritis	0.00102	0.0156	CbGpPWpGaD
Acetylsalicylic acid—TP53—tendon—psoriatic arthritis	0.000994	0.0313	CbGeAlD
Acetylsalicylic acid—NFKBIA—tendon—psoriatic arthritis	0.000978	0.0308	CbGeAlD
Acetylsalicylic acid—Melaena—Auranofin—psoriatic arthritis	0.000971	0.0279	CcSEcCtD
Acetylsalicylic acid—HSPA5—tendon—psoriatic arthritis	0.000958	0.0302	CbGeAlD
Acetylsalicylic acid—NFKBIA—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—NOD2—psoriatic arthritis	0.000945	0.0145	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Apoptosis—LTA—psoriatic arthritis	0.000898	0.0138	CbGpPWpGaD
Acetylsalicylic acid—TP53—Apoptosis—LTA—psoriatic arthritis	0.000888	0.0136	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—IL23-mediated signaling events—IL17A—psoriatic arthritis	0.000886	0.0136	CbGpPWpGaD
Acetylsalicylic acid—Diabetic—Methylprednisolone—psoriatic arthritis	0.000871	0.025	CcSEcCtD
Acetylsalicylic acid—NFKBIA—IL23-mediated signaling events—IL12B—psoriatic arthritis	0.000824	0.0126	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—tendon—psoriatic arthritis	0.000816	0.0257	CbGeAlD
Acetylsalicylic acid—Diabetic—Betamethasone—psoriatic arthritis	0.000792	0.0228	CcSEcCtD
Acetylsalicylic acid—Diabetic—Dexamethasone—psoriatic arthritis	0.000792	0.0228	CcSEcCtD
Acetylsalicylic acid—IKBKB—skin of body—psoriatic arthritis	0.000791	0.0249	CbGeAlD
Acetylsalicylic acid—IKBKB—NOD pathway—MEFV—psoriatic arthritis	0.000775	0.0119	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—IL-1 signaling pathway—REL—psoriatic arthritis	0.000766	0.0118	CbGpPWpGaD
Acetylsalicylic acid—Metabolic acidosis—Methylprednisolone—psoriatic arthritis	0.000736	0.0211	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Auranofin—psoriatic arthritis	0.000721	0.0207	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Activation of NF-kappaB in B cells—REL—psoriatic arthritis	0.000671	0.0103	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—tendon—psoriatic arthritis	0.000663	0.0209	CbGeAlD
Acetylsalicylic acid—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—MEFV—psoriatic arthritis	0.000661	0.0101	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—NOD pathway—NOD2—psoriatic arthritis	0.000656	0.0101	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—tendon—psoriatic arthritis	0.000602	0.019	CbGeAlD
Acetylsalicylic acid—Gastric irritation—Prednisone—psoriatic arthritis	0.000594	0.0171	CcSEcCtD
Acetylsalicylic acid—Diabetic—Methotrexate—psoriatic arthritis	0.000576	0.0166	CcSEcCtD
Acetylsalicylic acid—NFKBIA—TCR Signaling Pathway—REL—psoriatic arthritis	0.000517	0.00793	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Apoptosis—TNFRSF1B—psoriatic arthritis	0.000516	0.00791	CbGpPWpGaD
Acetylsalicylic acid—TP53—Apoptosis—TNFRSF1B—psoriatic arthritis	0.00051	0.00782	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—TNF alpha Signaling Pathway—REL—psoriatic arthritis	0.000508	0.00779	CbGpPWpGaD
Acetylsalicylic acid—TP53—Glucocorticoid receptor regulatory network—IL13—psoriatic arthritis	0.000503	0.00772	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—B Cell Receptor Signaling Pathway—REL—psoriatic arthritis	0.000487	0.00747	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Apoptosis Modulation and Signaling—TNFRSF1B—psoriatic arthritis	0.000484	0.00742	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—TNF alpha Signaling Pathway—TNFRSF1B—psoriatic arthritis	0.00048	0.00736	CbGpPWpGaD
Acetylsalicylic acid—TP53—Apoptosis Modulation and Signaling—TNFRSF1B—psoriatic arthritis	0.000478	0.00734	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriatic arthritis	0.000477	0.00732	CbGpPWpGaD
Acetylsalicylic acid—Peptic ulcer—Prednisolone—psoriatic arthritis	0.000474	0.0136	CcSEcCtD
Acetylsalicylic acid—IKBKB—Canonical NF-kappaB pathway—NOD2—psoriatic arthritis	0.000463	0.0071	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—IL23-mediated signaling events—NOS2—psoriatic arthritis	0.000462	0.00708	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—MAP kinase activation in TLR cascade—NOD2—psoriatic arthritis	0.000457	0.00701	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—IL17 signaling pathway—IL17A—psoriatic arthritis	0.000454	0.00696	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Downstream TCR signaling—HLA-DRB1—psoriatic arthritis	0.000447	0.00685	CbGpPWpGaD
Acetylsalicylic acid—Epigastric discomfort—Prednisone—psoriatic arthritis	0.000438	0.0126	CcSEcCtD
Acetylsalicylic acid—Peptic ulcer—Triamcinolone—psoriatic arthritis	0.000436	0.0125	CcSEcCtD
Acetylsalicylic acid—NFKBIA—TCR Signaling Pathway—IL17A—psoriatic arthritis	0.000435	0.00667	CbGpPWpGaD
Acetylsalicylic acid—Peptic ulcer—Methylprednisolone—psoriatic arthritis	0.000435	0.0125	CcSEcCtD
Acetylsalicylic acid—IKBKB—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—NOD2—psoriatic arthritis	0.00042	0.00644	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—TRAF6 Mediated Induction of proinflammatory cytokines—NOD2—psoriatic arthritis	0.000405	0.00621	CbGpPWpGaD
Acetylsalicylic acid—Anaemia—Auranofin—psoriatic arthritis	0.000402	0.0115	CcSEcCtD
Acetylsalicylic acid—IKBKB—Apoptosis—LTA—psoriatic arthritis	0.000399	0.00612	CbGpPWpGaD
Acetylsalicylic acid—Angioedema—Auranofin—psoriatic arthritis	0.000397	0.0114	CcSEcCtD
Acetylsalicylic acid—Peptic ulcer—Dexamethasone—psoriatic arthritis	0.000396	0.0114	CcSEcCtD
Acetylsalicylic acid—Peptic ulcer—Betamethasone—psoriatic arthritis	0.000396	0.0114	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Auranofin—psoriatic arthritis	0.000389	0.0112	CcSEcCtD
Acetylsalicylic acid—IKBKB—TNF receptor signaling pathway —TNFRSF1B—psoriatic arthritis	0.000371	0.00569	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—MyD88 cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.000366	0.00562	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Toll-like Receptor Signaling Pathway—IL12B—psoriatic arthritis	0.000366	0.00561	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—NOD1/2 Signaling Pathway—NOD2—psoriatic arthritis	0.000365	0.0056	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Class I MHC mediated antigen processing & presentation—HLA-C—psoriatic arthritis	0.000363	0.00557	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—psoriatic arthritis	0.000363	0.00556	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—TRAF6 Mediated Induction of proinflammatory cytokines—NOD2—psoriatic arthritis	0.000362	0.00555	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—MyD88 dependent cascade initiated on endosome—NOD2—psoriatic arthritis	0.000356	0.00546	CbGpPWpGaD
Acetylsalicylic acid—Thrombocytopenia—Auranofin—psoriatic arthritis	0.000347	0.00997	CcSEcCtD
Acetylsalicylic acid—Peptic ulcer—Prednisone—psoriatic arthritis	0.000344	0.00989	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Toll Like Receptor 9 (TLR9) Cascade—NOD2—psoriatic arthritis	0.000344	0.00527	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—IL-1 signaling pathway—REL—psoriatic arthritis	0.000341	0.00523	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—MyD88:Mal cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.000338	0.00518	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—EBV LMP1 signaling—TNF—psoriatic arthritis	0.000335	0.00514	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Canonical NF-kappaB pathway—TNF—psoriatic arthritis	0.000335	0.00514	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—TCR signaling—HLA-DRB1—psoriatic arthritis	0.000334	0.00512	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—MyD88 cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.000327	0.00502	CbGpPWpGaD
Acetylsalicylic acid—TP53—Testosterone—Prednisolone—psoriatic arthritis	0.000326	0.157	CbGdCrCtD
Acetylsalicylic acid—RPS6KA3—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—psoriatic arthritis	0.000324	0.00497	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—MyD88-independent cascade—NOD2—psoriatic arthritis	0.000324	0.00497	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—MyD88 dependent cascade initiated on endosome—NOD2—psoriatic arthritis	0.000318	0.00488	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Overview of nanoparticle effects—CRP—psoriatic arthritis	0.000316	0.00484	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Downstream signaling events of B Cell Receptor (BCR)—REL—psoriatic arthritis	0.000315	0.00483	CbGpPWpGaD
Acetylsalicylic acid—TP53—Folate Metabolism—CRP—psoriatic arthritis	0.000315	0.00483	CbGpPWpGaD
Acetylsalicylic acid—Eruption—Methotrexate—psoriatic arthritis	0.000313	0.00899	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Auranofin—psoriatic arthritis	0.000312	0.00896	CcSEcCtD
Acetylsalicylic acid—Ulcer—Triamcinolone—psoriatic arthritis	0.000308	0.00885	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Toll Like Receptor 9 (TLR9) Cascade—NOD2—psoriatic arthritis	0.000307	0.00471	CbGpPWpGaD
Acetylsalicylic acid—Contusion—Betamethasone—psoriatic arthritis	0.000303	0.0087	CcSEcCtD
Acetylsalicylic acid—Contusion—Dexamethasone—psoriatic arthritis	0.000303	0.0087	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—MyD88:Mal cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.000302	0.00463	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—psoriatic arthritis	0.000299	0.00459	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Activation of NF-kappaB in B cells—REL—psoriatic arthritis	0.000298	0.00457	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Interleukin-1 signaling—NOD2—psoriatic arthritis	0.000298	0.00456	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—NOD pathway—NOD2—psoriatic arthritis	0.000292	0.00447	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Activated TLR4 signalling—NOD2—psoriatic arthritis	0.000292	0.00447	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.000291	0.00446	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—MyD88-independent cascade—NOD2—psoriatic arthritis	0.00029	0.00444	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Rac1/Pak1/p38/MMP-2 pathway—NOS2—psoriatic arthritis	0.000287	0.0044	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.000286	0.00438	CbGpPWpGaD
Acetylsalicylic acid—TP53—Rac1/Pak1/p38/MMP-2 pathway—NOS2—psoriatic arthritis	0.000284	0.00435	CbGpPWpGaD
Acetylsalicylic acid—Liver disorder—Methotrexate—psoriatic arthritis	0.000282	0.00811	CcSEcCtD
Acetylsalicylic acid—Urticaria—Auranofin—psoriatic arthritis	0.000282	0.00809	CcSEcCtD
Acetylsalicylic acid—Ulcer—Dexamethasone—psoriatic arthritis	0.00028	0.00803	CcSEcCtD
Acetylsalicylic acid—Ulcer—Betamethasone—psoriatic arthritis	0.00028	0.00803	CcSEcCtD
Acetylsalicylic acid—NFKBIA—B Cell Activation—REL—psoriatic arthritis	0.000278	0.00427	CbGpPWpGaD
Acetylsalicylic acid—Haematemesis—Methotrexate—psoriatic arthritis	0.000277	0.00796	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Toll Like Receptor 4 (TLR4) Cascade—NOD2—psoriatic arthritis	0.000274	0.00421	CbGpPWpGaD
Acetylsalicylic acid—TP53—Danazol—Prednisone—psoriatic arthritis	0.000271	0.131	CbGdCrCtD
Acetylsalicylic acid—IKBKB—Leptin signaling pathway—REL—psoriatic arthritis	0.000266	0.00408	CbGpPWpGaD
Acetylsalicylic acid—Diabetes mellitus—Prednisolone—psoriatic arthritis	0.000264	0.0076	CcSEcCtD
Acetylsalicylic acid—Contusion—Prednisone—psoriatic arthritis	0.000264	0.00758	CcSEcCtD
Acetylsalicylic acid—PTGS1—skin of body—psoriatic arthritis	0.000263	0.00829	CbGeAlD
Acetylsalicylic acid—RPS6KA3—Activated TLR4 signalling—NOD2—psoriatic arthritis	0.000261	0.004	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—skin of body—psoriatic arthritis	0.000252	0.00792	CbGeAlD
Acetylsalicylic acid—NFKBIA—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—psoriatic arthritis	0.000251	0.00385	CbGpPWpGaD
Acetylsalicylic acid—Pruritus—Auranofin—psoriatic arthritis	0.000251	0.00721	CcSEcCtD
Acetylsalicylic acid—PTGS2—Overview of nanoparticle effects—CRP—psoriatic arthritis	0.000251	0.00384	CbGpPWpGaD
Acetylsalicylic acid—Hepatotoxicity—Methotrexate—psoriatic arthritis	0.000249	0.00716	CcSEcCtD
Acetylsalicylic acid—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NOD2—psoriatic arthritis	0.000249	0.00382	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Toll Like Receptor 4 (TLR4) Cascade—NOD2—psoriatic arthritis	0.000245	0.00376	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Toll-Like Receptors Cascades—NOD2—psoriatic arthritis	0.000244	0.00375	CbGpPWpGaD
Acetylsalicylic acid—Ulcer—Prednisone—psoriatic arthritis	0.000243	0.00699	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Triamcinolone—psoriatic arthritis	0.000243	0.00699	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Methylprednisolone—psoriatic arthritis	0.000243	0.00697	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Auranofin—psoriatic arthritis	0.000243	0.00697	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Triamcinolone—psoriatic arthritis	0.000236	0.00679	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Methylprednisolone—psoriatic arthritis	0.000235	0.113	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Dexamethasone—psoriatic arthritis	0.000231	0.111	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Betamethasone—psoriatic arthritis	0.000231	0.111	CbGdCrCtD
Acetylsalicylic acid—IKBKB—TCR Signaling Pathway—REL—psoriatic arthritis	0.00023	0.00352	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis—TNFRSF1B—psoriatic arthritis	0.000229	0.00352	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—IL23-mediated signaling events—TNF—psoriatic arthritis	0.000229	0.00352	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Fluocinonide—Triamcinolone—psoriatic arthritis	0.000226	0.109	CbGdCrCtD
Acetylsalicylic acid—IKBKB—TNF alpha Signaling Pathway—REL—psoriatic arthritis	0.000226	0.00346	CbGpPWpGaD
Acetylsalicylic acid—Vomiting—Auranofin—psoriatic arthritis	0.000225	0.00648	CcSEcCtD
Acetylsalicylic acid—Rash—Auranofin—psoriatic arthritis	0.000224	0.00642	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Auranofin—psoriatic arthritis	0.000223	0.00642	CcSEcCtD
Acetylsalicylic acid—TP53—Amyotrophic lateral sclerosis (ALS)—TNF—psoriatic arthritis	0.000222	0.0034	CbGpPWpGaD
Acetylsalicylic acid—Diabetes mellitus—Betamethasone—psoriatic arthritis	0.000221	0.00634	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Dexamethasone—psoriatic arthritis	0.000221	0.00634	CcSEcCtD
Acetylsalicylic acid—Purpura—Triamcinolone—psoriatic arthritis	0.000219	0.0063	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Toll-Like Receptors Cascades—NOD2—psoriatic arthritis	0.000218	0.00335	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Receptor Signaling Pathway—REL—psoriatic arthritis	0.000216	0.00332	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis Modulation and Signaling—TNFRSF1B—psoriatic arthritis	0.000215	0.0033	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Class I MHC mediated antigen processing & presentation—HLA-B—psoriatic arthritis	0.000215	0.0033	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TNF alpha Signaling Pathway—TNFRSF1B—psoriatic arthritis	0.000213	0.00327	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—MEFV—psoriatic arthritis	0.000213	0.00327	CbGpPWpGaD
Acetylsalicylic acid—Nausea—Auranofin—psoriatic arthritis	0.000211	0.00605	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Innate Immune System—MEFV—psoriatic arthritis	0.00021	0.00322	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—TWEAK Signaling Pathway—TNF—psoriatic arthritis	0.000207	0.00318	CbGpPWpGaD
Acetylsalicylic acid—Ulcer—Methotrexate—psoriatic arthritis	0.000203	0.00584	CcSEcCtD
Acetylsalicylic acid—PTGS1—tendon—psoriatic arthritis	0.0002	0.00631	CbGeAlD
Acetylsalicylic acid—IKBKB—Downstream TCR signaling—HLA-DRB1—psoriatic arthritis	0.000199	0.00305	CbGpPWpGaD
Acetylsalicylic acid—Respiratory failure—Methotrexate—psoriatic arthritis	0.000196	0.00563	CcSEcCtD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—REL—psoriatic arthritis	0.000195	0.003	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TCR Signaling Pathway—IL17A—psoriatic arthritis	0.000193	0.00297	CbGpPWpGaD
Acetylsalicylic acid—Diabetes mellitus—Prednisone—psoriatic arthritis	0.000192	0.00552	CcSEcCtD
Acetylsalicylic acid—PTGS2—tendon—psoriatic arthritis	0.000191	0.00603	CbGeAlD
Acetylsalicylic acid—Melaena—Methotrexate—psoriatic arthritis	0.000188	0.0054	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—MEFV—psoriatic arthritis	0.000188	0.00288	CbGpPWpGaD
Acetylsalicylic acid—Vascular purpura—Prednisone—psoriatic arthritis	0.000187	0.00537	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Ceramide signaling pathway—TNF—psoriatic arthritis	0.000186	0.00285	CbGpPWpGaD
Acetylsalicylic acid—Influenza—Triamcinolone—psoriatic arthritis	0.000183	0.00525	CcSEcCtD
Acetylsalicylic acid—Asthma—Triamcinolone—psoriatic arthritis	0.000183	0.00525	CcSEcCtD
Acetylsalicylic acid—TP53—Spinal Cord Injury—NOS2—psoriatic arthritis	0.00018	0.00277	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—NOD2—psoriatic arthritis	0.00018	0.00276	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—HLA-C—psoriatic arthritis	0.00018	0.00276	CbGpPWpGaD
Acetylsalicylic acid—Coma—Methotrexate—psoriatic arthritis	0.000176	0.00505	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Betamethasone—psoriatic arthritis	0.000175	0.00502	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Dexamethasone—psoriatic arthritis	0.000175	0.00502	CcSEcCtD
Acetylsalicylic acid—Purpura—Prednisone—psoriatic arthritis	0.000173	0.00498	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Prednisone—psoriatic arthritis	0.000167	0.0048	CcSEcCtD
Acetylsalicylic acid—IKBKB—MyD88 cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.000163	0.0025	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll-like Receptor Signaling Pathway—IL12B—psoriatic arthritis	0.000163	0.0025	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—psoriatic arthritis	0.000161	0.00247	CbGpPWpGaD
Acetylsalicylic acid—Diabetes mellitus—Methotrexate—psoriatic arthritis	0.000161	0.00461	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Prednisolone—psoriatic arthritis	0.00016	0.00459	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Prednisolone—psoriatic arthritis	0.000159	0.00457	CcSEcCtD
Acetylsalicylic acid—Polyuria—Methotrexate—psoriatic arthritis	0.000159	0.00457	CcSEcCtD
Acetylsalicylic acid—IKBKB—MyD88 dependent cascade initiated on endosome—NOD2—psoriatic arthritis	0.000158	0.00243	CbGpPWpGaD
Acetylsalicylic acid—Sweating—Methylprednisolone—psoriatic arthritis	0.000156	0.00448	CcSEcCtD
Acetylsalicylic acid—IKBKB—Type II diabetes mellitus—TNF—psoriatic arthritis	0.000154	0.00237	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—NOD2—psoriatic arthritis	0.000153	0.00234	CbGpPWpGaD
Acetylsalicylic acid—Hypokalaemia—Prednisone—psoriatic arthritis	0.000152	0.00437	CcSEcCtD
Acetylsalicylic acid—IKBKB—MyD88:Mal cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.00015	0.0023	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—EBV LMP1 signaling—TNF—psoriatic arthritis	0.000149	0.00229	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Canonical NF-kappaB pathway—TNF—psoriatic arthritis	0.000149	0.00229	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TCR signaling—HLA-DRB1—psoriatic arthritis	0.000148	0.00228	CbGpPWpGaD
Acetylsalicylic acid—Haemoglobin—Triamcinolone—psoriatic arthritis	0.000147	0.00422	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.000147	0.00422	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Triamcinolone—psoriatic arthritis	0.000146	0.0042	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.000146	0.00419	CcSEcCtD
Acetylsalicylic acid—IKBKB—MyD88-independent cascade—NOD2—psoriatic arthritis	0.000144	0.00221	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Overview of nanoparticle effects—TNF—psoriatic arthritis	0.000143	0.00219	CbGpPWpGaD
Acetylsalicylic acid—TP53—Folate Metabolism—TNF—psoriatic arthritis	0.000143	0.00219	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	0.000142	0.0682	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriatic arthritis	0.00014	0.00215	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—REL—psoriatic arthritis	0.00014	0.00215	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Betamethasone—psoriatic arthritis	0.00014	0.0671	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	0.00014	0.0671	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Signaling events mediated by HDAC Class I—TNF—psoriatic arthritis	0.000138	0.00211	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	0.000136	0.0656	CbGdCrCtD
Acetylsalicylic acid—IKBKB—TCR signaling in naïve CD4+ T cells—HLA-DRB1—psoriatic arthritis	0.000136	0.00208	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Metabolism of proteins—ACE—psoriatic arthritis	0.000135	0.00207	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by Interleukins—NOD2—psoriatic arthritis	0.000134	0.00206	CbGpPWpGaD
Acetylsalicylic acid—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000133	0.00383	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Betamethasone—psoriatic arthritis	0.000133	0.00383	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Betamethasone—psoriatic arthritis	0.000133	0.00381	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000133	0.00381	CcSEcCtD
Acetylsalicylic acid—IKBKB—Activated TLR4 signalling—NOD2—psoriatic arthritis	0.00013	0.00199	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.000129	0.00198	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—NOS2—psoriatic arthritis	0.000128	0.00196	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.000127	0.00195	CbGpPWpGaD
Acetylsalicylic acid—Angioedema—Prednisolone—psoriatic arthritis	0.000127	0.00364	CcSEcCtD
Acetylsalicylic acid—Vertigo—Prednisolone—psoriatic arthritis	0.000124	0.00357	CcSEcCtD
Acetylsalicylic acid—Syncope—Prednisolone—psoriatic arthritis	0.000124	0.00357	CcSEcCtD
Acetylsalicylic acid—IKBKB—B Cell Activation—REL—psoriatic arthritis	0.000124	0.0019	CbGpPWpGaD
Acetylsalicylic acid—TP53—Alzheimers Disease—TNF—psoriatic arthritis	0.000123	0.00189	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—MEFV—psoriatic arthritis	0.000122	0.00188	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—NOD2—psoriatic arthritis	0.000122	0.00187	CbGpPWpGaD
Acetylsalicylic acid—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000122	0.0035	CcSEcCtD
Acetylsalicylic acid—Asthma—Methotrexate—psoriatic arthritis	0.000121	0.00347	CcSEcCtD
Acetylsalicylic acid—Convulsion—Prednisolone—psoriatic arthritis	0.00012	0.00345	CcSEcCtD
Acetylsalicylic acid—Hypertension—Prednisolone—psoriatic arthritis	0.00012	0.00344	CcSEcCtD
Acetylsalicylic acid—HSPA5—MAPK Signaling Pathway—TNF—psoriatic arthritis	0.000119	0.00182	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Apoptosis—TNF—psoriatic arthritis	0.000119	0.00182	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—REL—psoriatic arthritis	0.000119	0.00182	CbGpPWpGaD
Acetylsalicylic acid—TP53—Circadian rythm related genes—NOS2—psoriatic arthritis	0.000118	0.00181	CbGpPWpGaD
Acetylsalicylic acid—TP53—Apoptosis—TNF—psoriatic arthritis	0.000118	0.0018	CbGpPWpGaD
Acetylsalicylic acid—Angioedema—Triamcinolone—psoriatic arthritis	0.000116	0.00334	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Prednisone—psoriatic arthritis	0.000116	0.00334	CcSEcCtD
Acetylsalicylic acid—Angioedema—Methylprednisolone—psoriatic arthritis	0.000116	0.00334	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Prednisone—psoriatic arthritis	0.000116	0.00332	CcSEcCtD
Acetylsalicylic acid—Vertigo—Triamcinolone—psoriatic arthritis	0.000114	0.00329	CcSEcCtD
Acetylsalicylic acid—Syncope—Triamcinolone—psoriatic arthritis	0.000114	0.00328	CcSEcCtD
Acetylsalicylic acid—Vertigo—Methylprednisolone—psoriatic arthritis	0.000114	0.00328	CcSEcCtD
Acetylsalicylic acid—Syncope—Methylprednisolone—psoriatic arthritis	0.000114	0.00327	CcSEcCtD
Acetylsalicylic acid—PTGS2—Overview of nanoparticle effects—TNF—psoriatic arthritis	0.000113	0.00174	CbGpPWpGaD
Acetylsalicylic acid—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000113	0.00325	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—REL—psoriatic arthritis	0.000112	0.00172	CbGpPWpGaD
Acetylsalicylic acid—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000112	0.00322	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000112	0.00321	CcSEcCtD
Acetylsalicylic acid—Shock—Prednisolone—psoriatic arthritis	0.000111	0.00319	CcSEcCtD
Acetylsalicylic acid—NFKBIA—TNF alpha Signaling Pathway—TNF—psoriatic arthritis	0.000111	0.0017	CbGpPWpGaD
Acetylsalicylic acid—Convulsion—Triamcinolone—psoriatic arthritis	0.00011	0.00317	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Prednisolone—psoriatic arthritis	0.00011	0.00317	CcSEcCtD
Acetylsalicylic acid—Convulsion—Methylprednisolone—psoriatic arthritis	0.00011	0.00316	CcSEcCtD
Acetylsalicylic acid—Hypertension—Triamcinolone—psoriatic arthritis	0.00011	0.00316	CcSEcCtD
Acetylsalicylic acid—Hypertension—Methylprednisolone—psoriatic arthritis	0.00011	0.00315	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Immune System—MEFV—psoriatic arthritis	0.000109	0.00168	CbGpPWpGaD
Acetylsalicylic acid—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000109	0.00314	CcSEcCtD
Acetylsalicylic acid—HSPA5—Immune System—HLA-C—psoriatic arthritis	0.000109	0.00167	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—HLA-C—psoriatic arthritis	0.000109	0.00167	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll-Like Receptors Cascades—NOD2—psoriatic arthritis	0.000109	0.00167	CbGpPWpGaD
Acetylsalicylic acid—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000108	0.00311	CcSEcCtD
Acetylsalicylic acid—ABCB1—Allograft Rejection—IL13—psoriatic arthritis	0.000108	0.00166	CbGpPWpGaD
Acetylsalicylic acid—Drowsiness—Methotrexate—psoriatic arthritis	0.000108	0.00309	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Innate Immune System—HLA-C—psoriatic arthritis	0.000108	0.00165	CbGpPWpGaD
Acetylsalicylic acid—Flushing—Prednisone—psoriatic arthritis	0.000107	0.00308	CcSEcCtD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—HLA-B—psoriatic arthritis	0.000106	0.00163	CbGpPWpGaD
Acetylsalicylic acid—Angioedema—Dexamethasone—psoriatic arthritis	0.000106	0.00303	CcSEcCtD
Acetylsalicylic acid—Angioedema—Betamethasone—psoriatic arthritis	0.000106	0.00303	CcSEcCtD
Acetylsalicylic acid—Confusional state—Methylprednisolone—psoriatic arthritis	0.000105	0.003	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000104	0.00299	CcSEcCtD
Acetylsalicylic acid—Vertigo—Betamethasone—psoriatic arthritis	0.000104	0.00298	CcSEcCtD
Acetylsalicylic acid—Vertigo—Dexamethasone—psoriatic arthritis	0.000104	0.00298	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000104	0.00298	CcSEcCtD
Acetylsalicylic acid—Syncope—Dexamethasone—psoriatic arthritis	0.000104	0.00298	CcSEcCtD
Acetylsalicylic acid—Syncope—Betamethasone—psoriatic arthritis	0.000104	0.00298	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HLA-C—psoriatic arthritis	0.000103	0.00158	CbGpPWpGaD
Acetylsalicylic acid—Sweating—Methotrexate—psoriatic arthritis	0.000103	0.00296	CcSEcCtD
Acetylsalicylic acid—Shock—Triamcinolone—psoriatic arthritis	0.000102	0.00294	CcSEcCtD
Acetylsalicylic acid—Shock—Methylprednisolone—psoriatic arthritis	0.000102	0.00293	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	0.000102	0.00156	CbGpPWpGaD
Acetylsalicylic acid—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000102	0.00292	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000102	0.00292	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Triamcinolone—psoriatic arthritis	0.000101	0.00291	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000101	0.00291	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000101	0.00289	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.0001	0.00288	CcSEcCtD
Acetylsalicylic acid—Convulsion—Dexamethasone—psoriatic arthritis	0.0001	0.00288	CcSEcCtD
Acetylsalicylic acid—Convulsion—Betamethasone—psoriatic arthritis	0.0001	0.00288	CcSEcCtD
Acetylsalicylic acid—Hypertension—Betamethasone—psoriatic arthritis	9.98e-05	0.00287	CcSEcCtD
Acetylsalicylic acid—Hypertension—Dexamethasone—psoriatic arthritis	9.98e-05	0.00287	CcSEcCtD
Acetylsalicylic acid—ABCB1—Allograft Rejection—IL17A—psoriatic arthritis	9.94e-05	0.00152	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Hemostasis—NOS2—psoriatic arthritis	9.92e-05	0.00152	CbGpPWpGaD
Acetylsalicylic acid—Haemoglobin—Methotrexate—psoriatic arthritis	9.71e-05	0.00279	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Methotrexate—psoriatic arthritis	9.66e-05	0.00278	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—HLA-C—psoriatic arthritis	9.62e-05	0.00148	CbGpPWpGaD
Acetylsalicylic acid—Anaphylactic shock—Dexamethasone—psoriatic arthritis	9.43e-05	0.00271	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Betamethasone—psoriatic arthritis	9.43e-05	0.00271	CcSEcCtD
Acetylsalicylic acid—IKBKB—Innate Immune System—MEFV—psoriatic arthritis	9.34e-05	0.00143	CbGpPWpGaD
Acetylsalicylic acid—Feeling abnormal—Prednisolone—psoriatic arthritis	9.32e-05	0.00268	CcSEcCtD
Acetylsalicylic acid—Anaemia—Prednisone—psoriatic arthritis	9.3e-05	0.00267	CcSEcCtD
Acetylsalicylic acid—Shock—Dexamethasone—psoriatic arthritis	9.28e-05	0.00267	CcSEcCtD
Acetylsalicylic acid—Shock—Betamethasone—psoriatic arthritis	9.28e-05	0.00267	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Triamcinolone—psoriatic arthritis	9.27e-05	0.00266	CcSEcCtD
Acetylsalicylic acid—PTGS1—Selenium Micronutrient Network—CRP—psoriatic arthritis	9.26e-05	0.00142	CbGpPWpGaD
Acetylsalicylic acid—Agitation—Prednisone—psoriatic arthritis	9.25e-05	0.00266	CcSEcCtD
Acetylsalicylic acid—ABCB1—Allograft Rejection—IL12B—psoriatic arthritis	9.24e-05	0.00142	CbGpPWpGaD
Acetylsalicylic acid—Thrombocytopenia—Betamethasone—psoriatic arthritis	9.24e-05	0.00265	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Dexamethasone—psoriatic arthritis	9.24e-05	0.00265	CcSEcCtD
Acetylsalicylic acid—IKBKB—TWEAK Signaling Pathway—TNF—psoriatic arthritis	9.21e-05	0.00141	CbGpPWpGaD
Acetylsalicylic acid—Tachycardia—Betamethasone—psoriatic arthritis	9.21e-05	0.00264	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Dexamethasone—psoriatic arthritis	9.21e-05	0.00264	CcSEcCtD
Acetylsalicylic acid—ALB—Vitamin B12 Metabolism—CRP—psoriatic arthritis	9.2e-05	0.00141	CbGpPWpGaD
Acetylsalicylic acid—Angioedema—Prednisone—psoriatic arthritis	9.2e-05	0.00264	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Triamcinolone—psoriatic arthritis	9.15e-05	0.00263	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Methylprednisolone—psoriatic arthritis	9.13e-05	0.00262	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Dexamethasone—psoriatic arthritis	9.12e-05	0.00262	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Betamethasone—psoriatic arthritis	9.12e-05	0.00262	CcSEcCtD
Acetylsalicylic acid—Vertigo—Prednisone—psoriatic arthritis	9.04e-05	0.0026	CcSEcCtD
Acetylsalicylic acid—Syncope—Prednisone—psoriatic arthritis	9.03e-05	0.00259	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Methotrexate—psoriatic arthritis	9.01e-05	0.00259	CcSEcCtD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	9e-05	0.00138	CbGpPWpGaD
Acetylsalicylic acid—Urticaria—Prednisolone—psoriatic arthritis	8.98e-05	0.00258	CcSEcCtD
Acetylsalicylic acid—TP53—Spinal Cord Injury—TNF—psoriatic arthritis	8.96e-05	0.00137	CbGpPWpGaD
Acetylsalicylic acid—Loss of consciousness—Prednisone—psoriatic arthritis	8.85e-05	0.00254	CcSEcCtD
Acetylsalicylic acid—Convulsion—Prednisone—psoriatic arthritis	8.72e-05	0.0025	CcSEcCtD
Acetylsalicylic acid—Hypertension—Prednisone—psoriatic arthritis	8.69e-05	0.0025	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Prednisone—psoriatic arthritis	8.57e-05	0.00246	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Triamcinolone—psoriatic arthritis	8.57e-05	0.00246	CcSEcCtD
Acetylsalicylic acid—IKBKB—TNF receptor signaling pathway —TNF—psoriatic arthritis	8.56e-05	0.00131	CbGpPWpGaD
Acetylsalicylic acid—Feeling abnormal—Methylprednisolone—psoriatic arthritis	8.55e-05	0.00246	CcSEcCtD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HLA-C—psoriatic arthritis	8.53e-05	0.00131	CbGpPWpGaD
Acetylsalicylic acid—Hypersensitivity—Prednisolone—psoriatic arthritis	8.33e-05	0.00239	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Betamethasone—psoriatic arthritis	8.3e-05	0.00239	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Dexamethasone—psoriatic arthritis	8.3e-05	0.00239	CcSEcCtD
Acetylsalicylic acid—Urticaria—Triamcinolone—psoriatic arthritis	8.26e-05	0.00237	CcSEcCtD
Acetylsalicylic acid—Urticaria—Methylprednisolone—psoriatic arthritis	8.24e-05	0.00237	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Prednisone—psoriatic arthritis	8.21e-05	0.00236	CcSEcCtD
Acetylsalicylic acid—Shock—Prednisone—psoriatic arthritis	8.08e-05	0.00232	CcSEcCtD
Acetylsalicylic acid—HSPA5—Immune System—NOD2—psoriatic arthritis	8.02e-05	0.00123	CbGpPWpGaD
Acetylsalicylic acid—Tachycardia—Prednisone—psoriatic arthritis	8.02e-05	0.0023	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	7.95e-05	0.00122	CbGpPWpGaD
Acetylsalicylic acid—Hyperhidrosis—Prednisone—psoriatic arthritis	7.94e-05	0.00228	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Innate Immune System—NOD2—psoriatic arthritis	7.91e-05	0.00121	CbGpPWpGaD
Acetylsalicylic acid—Anaemia—Methotrexate—psoriatic arthritis	7.77e-05	0.00223	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Dexamethasone—psoriatic arthritis	7.77e-05	0.00223	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Betamethasone—psoriatic arthritis	7.77e-05	0.00223	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Triamcinolone—psoriatic arthritis	7.66e-05	0.0022	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Methylprednisolone—psoriatic arthritis	7.64e-05	0.0022	CcSEcCtD
Acetylsalicylic acid—Vertigo—Methotrexate—psoriatic arthritis	7.56e-05	0.00217	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Methotrexate—psoriatic arthritis	7.53e-05	0.00216	CcSEcCtD
Acetylsalicylic acid—Urticaria—Betamethasone—psoriatic arthritis	7.49e-05	0.00215	CcSEcCtD
Acetylsalicylic acid—Urticaria—Dexamethasone—psoriatic arthritis	7.49e-05	0.00215	CcSEcCtD
Acetylsalicylic acid—ALB—Folate Metabolism—CRP—psoriatic arthritis	7.49e-05	0.00115	CbGpPWpGaD
Acetylsalicylic acid—Dizziness—Prednisolone—psoriatic arthritis	7.48e-05	0.00215	CcSEcCtD
Acetylsalicylic acid—IKBKB—Cardiac Hypertrophic Response—TNF—psoriatic arthritis	7.42e-05	0.00114	CbGpPWpGaD
Acetylsalicylic acid—Pruritus—Triamcinolone—psoriatic arthritis	7.36e-05	0.00211	CcSEcCtD
Acetylsalicylic acid—PTGS2—Selenium Micronutrient Network—CRP—psoriatic arthritis	7.35e-05	0.00113	CbGpPWpGaD
Acetylsalicylic acid—Pruritus—Methylprednisolone—psoriatic arthritis	7.34e-05	0.00211	CcSEcCtD
Acetylsalicylic acid—Convulsion—Methotrexate—psoriatic arthritis	7.29e-05	0.00209	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Prednisone—psoriatic arthritis	7.23e-05	0.00208	CcSEcCtD
Acetylsalicylic acid—TP53—Apoptosis—TNF—psoriatic arthritis	7.2e-05	0.0011	CbGpPWpGaD
Acetylsalicylic acid—Chest pain—Methotrexate—psoriatic arthritis	7.16e-05	0.00206	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Methotrexate—psoriatic arthritis	7.16e-05	0.00206	CcSEcCtD
Acetylsalicylic acid—Rash—Prednisolone—psoriatic arthritis	7.13e-05	0.00205	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Prednisolone—psoriatic arthritis	7.12e-05	0.00205	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Methylprednisolone—psoriatic arthritis	7.1e-05	0.00204	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—NOD2—psoriatic arthritis	7.07e-05	0.00108	CbGpPWpGaD
Acetylsalicylic acid—Confusional state—Methotrexate—psoriatic arthritis	6.92e-05	0.00199	CcSEcCtD
Acetylsalicylic acid—Dizziness—Triamcinolone—psoriatic arthritis	6.87e-05	0.00197	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Methotrexate—psoriatic arthritis	6.87e-05	0.00197	CcSEcCtD
Acetylsalicylic acid—Dizziness—Methylprednisolone—psoriatic arthritis	6.86e-05	0.00197	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Immune System—REL—psoriatic arthritis	6.81e-05	0.00104	CbGpPWpGaD
Acetylsalicylic acid—Feeling abnormal—Prednisone—psoriatic arthritis	6.77e-05	0.00194	CcSEcCtD
Acetylsalicylic acid—TP53—MAPK Signaling Pathway—TNF—psoriatic arthritis	6.75e-05	0.00104	CbGpPWpGaD
Acetylsalicylic acid—Thrombocytopenia—Methotrexate—psoriatic arthritis	6.72e-05	0.00193	CcSEcCtD
Acetylsalicylic acid—Nausea—Prednisolone—psoriatic arthritis	6.71e-05	0.00193	CcSEcCtD
Acetylsalicylic acid—Pruritus—Betamethasone—psoriatic arthritis	6.67e-05	0.00192	CcSEcCtD
Acetylsalicylic acid—Pruritus—Dexamethasone—psoriatic arthritis	6.67e-05	0.00192	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Methotrexate—psoriatic arthritis	6.64e-05	0.00191	CcSEcCtD
Acetylsalicylic acid—Vomiting—Triamcinolone—psoriatic arthritis	6.61e-05	0.0019	CcSEcCtD
Acetylsalicylic acid—Vomiting—Methylprednisolone—psoriatic arthritis	6.6e-05	0.00189	CcSEcCtD
Acetylsalicylic acid—Rash—Triamcinolone—psoriatic arthritis	6.55e-05	0.00188	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Triamcinolone—psoriatic arthritis	6.55e-05	0.00188	CcSEcCtD
Acetylsalicylic acid—Rash—Methylprednisolone—psoriatic arthritis	6.54e-05	0.00188	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Methylprednisolone—psoriatic arthritis	6.53e-05	0.00188	CcSEcCtD
Acetylsalicylic acid—Urticaria—Prednisone—psoriatic arthritis	6.53e-05	0.00187	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Dexamethasone—psoriatic arthritis	6.45e-05	0.00185	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Betamethasone—psoriatic arthritis	6.45e-05	0.00185	CcSEcCtD
Acetylsalicylic acid—HSPA5—Immune System—HLA-B—psoriatic arthritis	6.45e-05	0.00099	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—HLA-B—psoriatic arthritis	6.43e-05	0.000986	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—HLA-B—psoriatic arthritis	6.36e-05	0.000976	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—NOD2—psoriatic arthritis	6.27e-05	0.000962	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HLA-C—psoriatic arthritis	6.27e-05	0.000961	CbGpPWpGaD
Acetylsalicylic acid—Dizziness—Betamethasone—psoriatic arthritis	6.24e-05	0.00179	CcSEcCtD
Acetylsalicylic acid—Dizziness—Dexamethasone—psoriatic arthritis	6.24e-05	0.00179	CcSEcCtD
Acetylsalicylic acid—Nausea—Triamcinolone—psoriatic arthritis	6.18e-05	0.00177	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	6.16e-05	0.000946	CbGpPWpGaD
Acetylsalicylic acid—Nausea—Methylprednisolone—psoriatic arthritis	6.16e-05	0.00177	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Methotrexate—psoriatic arthritis	6.12e-05	0.00176	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HLA-B—psoriatic arthritis	6.11e-05	0.000937	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—MAPK Signaling Pathway—TNF—psoriatic arthritis	6.11e-05	0.000937	CbGpPWpGaD
Acetylsalicylic acid—Somnolence—Methotrexate—psoriatic arthritis	6.1e-05	0.00175	CcSEcCtD
Acetylsalicylic acid—TP53—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	6.09e-05	0.000935	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—REL—psoriatic arthritis	6.09e-05	0.000934	CbGpPWpGaD
Acetylsalicylic acid—Hypersensitivity—Prednisone—psoriatic arthritis	6.05e-05	0.00174	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Methotrexate—psoriatic arthritis	6.04e-05	0.00174	CcSEcCtD
Acetylsalicylic acid—Vomiting—Dexamethasone—psoriatic arthritis	6e-05	0.00172	CcSEcCtD
Acetylsalicylic acid—Vomiting—Betamethasone—psoriatic arthritis	6e-05	0.00172	CcSEcCtD
Acetylsalicylic acid—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriatic arthritis	5.98e-05	0.000918	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—CRP—psoriatic arthritis	5.95e-05	0.000912	CbGpPWpGaD
Acetylsalicylic acid—Rash—Dexamethasone—psoriatic arthritis	5.95e-05	0.00171	CcSEcCtD
Acetylsalicylic acid—Rash—Betamethasone—psoriatic arthritis	5.95e-05	0.00171	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Betamethasone—psoriatic arthritis	5.94e-05	0.00171	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Dexamethasone—psoriatic arthritis	5.94e-05	0.00171	CcSEcCtD
Acetylsalicylic acid—Pruritus—Prednisone—psoriatic arthritis	5.81e-05	0.00167	CcSEcCtD
Acetylsalicylic acid—HSPA5—Immune System—CRP—psoriatic arthritis	5.7e-05	0.000875	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—HLA-B—psoriatic arthritis	5.69e-05	0.000872	CbGpPWpGaD
Acetylsalicylic acid—Feeling abnormal—Methotrexate—psoriatic arthritis	5.66e-05	0.00163	CcSEcCtD
Acetylsalicylic acid—TP53—Hemostasis—NOS2—psoriatic arthritis	5.63e-05	0.000864	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—CRP—psoriatic arthritis	5.62e-05	0.000863	CbGpPWpGaD
Acetylsalicylic acid—Diarrhoea—Prednisone—psoriatic arthritis	5.62e-05	0.00161	CcSEcCtD
Acetylsalicylic acid—Nausea—Betamethasone—psoriatic arthritis	5.6e-05	0.00161	CcSEcCtD
Acetylsalicylic acid—Nausea—Dexamethasone—psoriatic arthritis	5.6e-05	0.00161	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Immune System—HLA-C—psoriatic arthritis	5.6e-05	0.000859	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	5.59e-05	0.000858	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—HLA-DRB1—psoriatic arthritis	5.46e-05	0.000838	CbGpPWpGaD
Acetylsalicylic acid—Urticaria—Methotrexate—psoriatic arthritis	5.45e-05	0.00157	CcSEcCtD
Acetylsalicylic acid—IKBKB—Immune System—MEFV—psoriatic arthritis	5.44e-05	0.000835	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—HLA-DRB1—psoriatic arthritis	5.44e-05	0.000835	CbGpPWpGaD
Acetylsalicylic acid—Dizziness—Prednisone—psoriatic arthritis	5.43e-05	0.00156	CcSEcCtD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—NOS2—psoriatic arthritis	5.3e-05	0.000813	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis—TNF—psoriatic arthritis	5.29e-05	0.000811	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	5.29e-05	0.000811	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriatic arthritis	5.23e-05	0.000802	CbGpPWpGaD
Acetylsalicylic acid—Vomiting—Prednisone—psoriatic arthritis	5.22e-05	0.0015	CcSEcCtD
Acetylsalicylic acid—Rash—Prednisone—psoriatic arthritis	5.18e-05	0.00149	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Prednisone—psoriatic arthritis	5.17e-05	0.00149	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	5.17e-05	0.000793	CbGpPWpGaD
Acetylsalicylic acid—Hypersensitivity—Methotrexate—psoriatic arthritis	5.06e-05	0.00145	CcSEcCtD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HLA-B—psoriatic arthritis	5.04e-05	0.000774	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—CRP—psoriatic arthritis	5.03e-05	0.000771	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—REL—psoriatic arthritis	4.99e-05	0.000765	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TNF alpha Signaling Pathway—TNF—psoriatic arthritis	4.92e-05	0.000754	CbGpPWpGaD
Acetylsalicylic acid—Nausea—Prednisone—psoriatic arthritis	4.88e-05	0.0014	CcSEcCtD
Acetylsalicylic acid—Pruritus—Methotrexate—psoriatic arthritis	4.86e-05	0.0014	CcSEcCtD
Acetylsalicylic acid—IKBKB—Innate Immune System—HLA-C—psoriatic arthritis	4.78e-05	0.000734	CbGpPWpGaD
Acetylsalicylic acid—Diarrhoea—Methotrexate—psoriatic arthritis	4.7e-05	0.00135	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Immune System—NOD2—psoriatic arthritis	4.61e-05	0.000707	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HLA-C—psoriatic arthritis	4.59e-05	0.000704	CbGpPWpGaD
Acetylsalicylic acid—Dizziness—Methotrexate—psoriatic arthritis	4.54e-05	0.0013	CcSEcCtD
Acetylsalicylic acid—IKBKB—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	4.53e-05	0.000694	CbGpPWpGaD
Acetylsalicylic acid—Vomiting—Methotrexate—psoriatic arthritis	4.37e-05	0.00125	CcSEcCtD
Acetylsalicylic acid—Rash—Methotrexate—psoriatic arthritis	4.33e-05	0.00124	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Methotrexate—psoriatic arthritis	4.32e-05	0.00124	CcSEcCtD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	4.27e-05	0.000655	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Selenium Micronutrient Network—TNF—psoriatic arthritis	4.19e-05	0.000643	CbGpPWpGaD
Acetylsalicylic acid—ALB—Vitamin B12 Metabolism—TNF—psoriatic arthritis	4.17e-05	0.000639	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—NOD2—psoriatic arthritis	4.12e-05	0.000632	CbGpPWpGaD
Acetylsalicylic acid—Nausea—Methotrexate—psoriatic arthritis	4.08e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Immune System—HLA-B—psoriatic arthritis	3.71e-05	0.000568	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	3.53e-05	0.000542	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—NOD2—psoriatic arthritis	3.52e-05	0.00054	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—NOS2—psoriatic arthritis	3.44e-05	0.000528	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—TNF—psoriatic arthritis	3.39e-05	0.00052	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Selenium Micronutrient Network—TNF—psoriatic arthritis	3.33e-05	0.00051	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HLA-B—psoriatic arthritis	3.31e-05	0.000508	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CRP—psoriatic arthritis	3.28e-05	0.000502	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HLA-DRB1—psoriatic arthritis	3.14e-05	0.000481	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TNF—psoriatic arthritis	3.04e-05	0.000466	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—REL—psoriatic arthritis	3.03e-05	0.000464	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CRP—psoriatic arthritis	2.93e-05	0.000449	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—HLA-B—psoriatic arthritis	2.83e-05	0.000434	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HLA-DRB1—psoriatic arthritis	2.8e-05	0.00043	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-C—psoriatic arthritis	2.79e-05	0.000427	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HLA-B—psoriatic arthritis	2.72e-05	0.000417	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—TNF—psoriatic arthritis	2.69e-05	0.000413	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TNF—psoriatic arthritis	2.63e-05	0.000404	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—TNF—psoriatic arthritis	2.58e-05	0.000395	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—TNF—psoriatic arthritis	2.57e-05	0.000394	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CRP—psoriatic arthritis	2.5e-05	0.000383	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	2.3e-05	0.000353	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—NOD2—psoriatic arthritis	2.05e-05	0.000314	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	1.79e-05	0.000275	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-B—psoriatic arthritis	1.65e-05	0.000253	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CRP—psoriatic arthritis	1.46e-05	0.000223	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DRB1—psoriatic arthritis	1.39e-05	0.000214	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NOS2—psoriatic arthritis	1.34e-05	0.000205	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	1.27e-05	0.000195	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOS2—psoriatic arthritis	8.01e-06	0.000123	CbGpPWpGaD
